Feds threaten Sanofi over proposed 340B changes
The U.S. government agency Health Resources & Services Administration warned Sanofi about facing sanctions for changing payment methods in the 340B Drug Discount Program. The agency stated that Sanofi could be terminated from the program if it proceeds with the changes without approval from the Department of Health and Human Services. Sanofi planned to provide…